News for '-sun-pharma'

Sensex erases gains; drops 134 points at close

Sensex erases gains; drops 134 points at close

Rediff.com18 Sep 2020

HDFC Bank was the top loser in the Sensex pack, shedding over 2 per cent, followed by Kotak Bank, Bajaj Finserv, Maruti, Titan, SBI, HUL, HDFC and Tata Steel. On the other hand, Bharti Airtel, M&M, NTPC, Tech Mahindra, Sun Pharma and PowerGrid were among the gainers.

Sensex tanks 470 points; Nifty drops below 14,300

Sensex tanks 470 points; Nifty drops below 14,300

Rediff.com18 Jan 2021

ONGC was the top loser in the Sensex pack, shedding around 5 per cent, followed by Sun Pharma, PowerGrid, Bajaj Finance, IndusInd Bank, Dr Reddy's and Maruti. On the other hand, Reliance Industries, Titan, HDFC Bank and ITC were the gainers.

Sensex rallies 412 points in volatile trade

Sensex rallies 412 points in volatile trade

Rediff.com8 Apr 2022

The Sensex jumped 412.23 points on Friday, braving heavy volatility during the day, amid the Reserve Bank of India maintaining status quo on the benchmark lending rate and buying in index heavyweights Reliance Industries Limited and ITC. The BSE Sensex climbed 412.23 points or 0.70 per cent to settle at 59,447.18. During the day, the benchmark hit a high of 59,654.44 and a low 58,876.36. The Nifty also gained 144.80 points or 0.82 per cent to finish at 17,784.35.

Sensex ends in red; sheds 291 points on profit-booking

Sensex ends in red; sheds 291 points on profit-booking

Rediff.com19 May 2021

Bajaj Finserv was the top loser in the Sensex pack, shedding around 2 per cent, followed by HDFC, M&M, Bharti Airtel, UltraTech Cement and Kotak Bank. NSE Nifty fell 77.95 points to 15,030.15.

Six Sensex companies add Rs 53,284.6 cr to market valuation

Six Sensex companies add Rs 53,284.6 cr to market valuation

Rediff.com19 Apr 2015

Sun Pharma and ONGC emerging as biggest gainers

Markets end flat, bank, auto stocks restrict gains

Markets end flat, bank, auto stocks restrict gains

Rediff.com19 Aug 2019

Top gainers in the Sensex pack included Sun Pharma, TechM, Axis Bank, L&T, Reliance Industries and ICICI Bank, which rose up to 2.66 per cent.

Sensex snaps 6-day winning run to end 129 pts lower

Sensex snaps 6-day winning run to end 129 pts lower

Rediff.com4 Jun 2020

Asian Paints was the top laggard in the Sensex pack, falling around 5 per cent, followed by Bajaj Finance, HDFC, IndusInd Bank, Axis Bank and Kotak Bank. On the other hand, Tech Mahindra, Sun Pharma, Bharti Airtel and HCL Tech were among the gainers.

Shanghvi, Telenor, IDFC Bank withdraw from payments bank

Shanghvi, Telenor, IDFC Bank withdraw from payments bank

Rediff.com20 May 2016

Telenor Financial Services, IDFC Bank and Sun Pharma's Dilip Shanghvi have decided to withdraw their licence to set up a payments bank.

Sensex soars 879 pts as India begins to unlock

Sensex soars 879 pts as India begins to unlock

Rediff.com1 Jun 2020

Bajaj Finance was the top gainer in the Sensex pack, rising around 11 per cent, followed by Titan, Tata Steel, SBI, M&M, HDFC, IndusInd Bank and Reliance Industries. On the other hand, Sun Pharma, Nestle India and UltraTech Cement were among the laggards.

Sensex soars over 400 points; Nifty reclaims 11,500 mark

Sensex soars over 400 points; Nifty reclaims 11,500 mark

Rediff.com28 Mar 2019

In the Sensex pack, gainers included HCL Tech, SBI, ITC, Bharti Airtel, Sun Pharma, Yes Bank, Axis Bank, TCS, Asian Paints, ICICI Bank, TCS, Bajaj Finance and Infosys, jumping up to 3.84 per cent.

Top seven companies lose Rs 51k cr in market cap

Top seven companies lose Rs 51k cr in market cap

Rediff.com24 Jan 2016

Only TCS, Sun Pharma and HDFC notched up gains in their m-cap

RIL, Infy lift D-Street; Sensex up 77 pts to close at new peak

RIL, Infy lift D-Street; Sensex up 77 pts to close at new peak

Rediff.com14 Jun 2021

Reliance Industries was the top gainer in the Sensex pack, rising around 1.5 per cent, followed by Bajaj Finance, ONGC, Infosys, PowerGrid, L&T and IndusInd Bank. NSE Nifty advanced 12.50 points to its fresh record of 15,811.85.

Sensex rises for 3rd day, gains 142 points

Sensex rises for 3rd day, gains 142 points

Rediff.com10 Aug 2020

L&T was the top gainer in the Sensex pack, rallying 4.81 per cent, followed by M&M, Sun Pharma, Tech Mahindra, NTPC, SBI, ICICI Bank and Titan.

Lupin aims to enter Chinese market in the next one year

Lupin aims to enter Chinese market in the next one year

Rediff.com8 Feb 2021

Once a difficult market to crack, in recent years, China has relatively opened up its drug market, enacting reforms and speeding up approval time.

Sensex tanks 587 points; HDFC Bank slumps over 3%

Sensex tanks 587 points; HDFC Bank slumps over 3%

Rediff.com19 Jul 2021

HDFC Bank was the top loser in the Sensex pack followed by IndusInd Bank, Axis Bank, HDFC, Maruti and Bajaj Finance. NSE Nifty fell 171 points to 15,752.40.

Top nine cos take Rs 47,139.45 cr hit in market valuation

Top nine cos take Rs 47,139.45 cr hit in market valuation

Rediff.com6 Dec 2015

HDFC worst hit with Rs 9,177 cr erosion; Sun Pharma only firm to have come out a gainer

Financial, IT stocks drag Sensex down 536 points

Financial, IT stocks drag Sensex down 536 points

Rediff.com24 Apr 2020

Bajaj Finance was the top laggard in the Sensex pack, dropping over 9 per cent, followed by Axis Bank, IndusInd Bank, HDFC, ICICI Bank and M&M. Reliance Industries, however, capped the losses by rallying over 3 per cent. Sun Pharma, Hero MotoCorp, L&T, PowerGrid and Bajaj Auto were also among the gainers.

Index heavyweights drag Sensex down 189 points

Index heavyweights drag Sensex down 189 points

Rediff.com28 Jun 2021

Titan was the top loser in the Sensex pack, shedding over 1 per cent, followed by TCS, HCL Tech, Reliance Industries, UltraTech Cement and Bharti Airtel. NSE Nifty settled 45.65 points down at 15,814.70.

Sensex ends 239 pts higher on bank stocks

Sensex ends 239 pts higher on bank stocks

Rediff.com9 Apr 2019

Yes Bank was the biggest gainer in the Sensex pack, climbing 4.08 per cent, followed by Tata Motors, ICICI Bank, Bajaj Auto, Coal India, Hero MotoCorp, HCL Tech, Vedanta, Sun Pharma, Axis Bank, Maruti, ITC, IndusInd Bank, TCS, HUL and SBI, rising up to 2.67 per cent.

Sensex advances 153 points amid Omicron worries

Sensex advances 153 points amid Omicron worries

Rediff.com29 Nov 2021

Kotak Bank rose the most among Sensex scrips, spurting 2.92 per cent amid reports that LIC will up its stake in the private lender to 10 per cent. Gains in HCL Tech, TCS, Infosys, HDFC Bank, Bajaj Finance and Titan helped Sensex close in the green. NSE Nifty edged higher by 27.50 points to end at 17,053.95.

Sensex spurts 140 points ahead of poll results

Sensex spurts 140 points ahead of poll results

Rediff.com22 May 2019

IndusInd Bank was the biggest gainer in the Sensex pack, rallying 4.84 per cent, followed by Sun Pharma, Bajaj Auto, Bharti Airtel, Coal India, Tata Motors, SBI, ICICI Bank, Hero MotoCorp, ONGC, HDFC, Vedanta, L&T, Kotak Bank, Maruti and Axis Bank, ending up to 2.92 per cent higher.

After swinging 568 points, Sensex finally settles up 264 pts

After swinging 568 points, Sensex finally settles up 264 pts

Rediff.com30 Aug 2019

Top gainers in the Sensex pack included Yes Bank, Sun Pharma, IndusInd Bank, Tata Steel, HUL, Vedanta, Tata Motors, ICICI Bank, ITC, HDFC and Bajaj Auto, that rose up to 3.75 per cent.

Sensex ends below 40K as virus fears grow

Sensex ends below 40K as virus fears grow

Rediff.com26 Feb 2020

On the Sensex chart, Sun Pharma was the top loser, followed by Maruti, L&T, Hero Motocorp, Infosys, ONGC and RIL.

Sensex ends 82 pts lower; Nifty slips below 11,800

Sensex ends 82 pts lower; Nifty slips below 11,800

Rediff.com25 Feb 2020

Sun Pharma was the top loser in the Sensex pack, shedding 2.37 per cent, followed by HCL Tech, Reliance Industries, IndusInd Bank and L&T.

Bank, auto stocks drag Sensex down 289 points

Bank, auto stocks drag Sensex down 289 points

Rediff.com30 Jul 2019

In the Sensex pack, Yes bank emerged as the biggest loser, falling 9.13 per cent, followed by IndusInd Bank (6.6 per cent), HeroMotoCorp (6.01 per cent), Sun Pharma (4.79 per cent) and SBI (4.70 per cent).

Sensex ends lower for 3rd day; Tata Steel tanks 6.95%

Sensex ends lower for 3rd day; Tata Steel tanks 6.95%

Rediff.com10 May 2022

Equity indices failed to hold on to their gains in see-saw trade on Tuesday, ending in the red for the third straight session despite a tentative recovery in global equities. The rupee too bounced back from historic lows, but the overall sentiment remained risk-averse amid concerns over economic recovery in a high interest rate scenario. The 30-share BSE Sensex had a choppy start but gained momentum in mid-session trade. However, it succumbed to selling pressure towards the fag end to close 105.82 points or 0.19 per cent lower at 54,364.85. On similar lines, the broader NSE Nifty declined 61.80 points or 0.38 per cent to finish at 16,240.05.

Sun gets RBI nod for transfer of Ranbaxy overseas investments

Sun gets RBI nod for transfer of Ranbaxy overseas investments

Rediff.com24 Mar 2015

Sun gets RBI nod for transfer of Ranbaxy overseas investments.

Clearances for Sun-Ranbaxy merger may be delayed

Clearances for Sun-Ranbaxy merger may be delayed

Rediff.com20 Jun 2014

Typically, CCI takes decisions related to M&As within 30 days, though it can do so within 210 days of the filing of application.

Financial stocks drag Sensex down 87 points

Financial stocks drag Sensex down 87 points

Rediff.com22 Mar 2021

IndusInd Bank was the top loser in the Sensex pack, shedding around 4 per cent, followed by PowerGrid, ICICI Bank, HDFC Bank, Axis Bank and Bajaj Finance. NSE Nifty dipped 7.60 points to 14,736.40.

Merck arm sues Sun over cancer drug

Merck arm sues Sun over cancer drug

Rediff.com21 Sep 2010

Merck arm sues Sun over cancer drugSchering Corporation, part of multinational pharma company Merck & Co, and London-based Cancer Research Technology Ltd have sued Sun Pharmaceutical for allegedly infringing patent rights on the world's largest selling brain cancer drug, Temodar.

Key mantra for India's pharma sector in 2023

Key mantra for India's pharma sector in 2023

Rediff.com21 Dec 2022

Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of inflation and pricing pressures in the global markets. While R&D investment, market competitiveness, regulatory scrutiny, and domestic price regulations are expected to shape the growth of generics and injectable products, concerns such as price control and customs duties on medical equipment will continue to bother the healthcare industry in 2023. The industry believes that in view of India's G20 Presidency, digital health innovation, achieving universal health coverage, improving healthcare infrastructure and delivery will continue to be the key driving factors in 2023.

Dilip Shanghvi moves into top gear to turn around Ranbaxy

Dilip Shanghvi moves into top gear to turn around Ranbaxy

Rediff.com31 Jul 2015

Sun Pharma expects synergy benefits by next fiscal.

Sensex rallies 986 points; rate-sensitive stocks soar post RBI boost

Sensex rallies 986 points; rate-sensitive stocks soar post RBI boost

Rediff.com17 Apr 2020

Axis Bank was the top gainer in the Sensex pack, surging over 13 per cent, followed by ICICI Bank, IndusInd Bank, Maruti, TCS, Kotak Bank and Reliance Industries. On the other hand, Nestle India, HUL, Tech Mahindra and Sun Pharma ended in the red. NSE Nifty zoomed 273.95 points, or 3.03 per cent, to finish at 9,266.75.

Sensex rebounds 254 pts; banking, metal stocks rally

Sensex rebounds 254 pts; banking, metal stocks rally

Rediff.com16 Oct 2020

On the Sensex chart, Tata Steel, HDFC Bank, Ultratech Cement, PowerGrid, ONGC, Kotak Bank and Axis Bank were among prominent gainers. Nifty settled 82.10 points or 0.70 per cent up at 11,762.45.

Sensex tanks 433 pts; Nifty gives up 11,200 level

Sensex tanks 433 pts; Nifty gives up 11,200 level

Rediff.com14 Aug 2020

Axis Bank was the top loser in the Sensex pack, falling around 3 per cent, followed by SBI, M&M, Bajaj Finance, ITC, HDFC Bank, HCL Tech and IndusInd Bank.

Sensex ends 87 points higher on positive Asian cues

Sensex ends 87 points higher on positive Asian cues

Rediff.com14 Oct 2019

Tata Motors was the top gainer in the Sensex pack rallying 5.32 per cent. Among other prominent gainers were Bharti Airtel, IndusInd Bank, Sun Pharma, Axis Bank, Maruti Suzuki, Bajaj Auto and TCS.

Sensex halts 3-day decline, rebounds over 500 pts amid F&O expiry

Sensex halts 3-day decline, rebounds over 500 pts amid F&O expiry

Rediff.com26 May 2022

Equity benchmarks mustered gains for the first time this week on Thursday as investors piled into the recently-battered metal, bank and IT stocks amid expiry of monthly derivative contracts. Snapping its three-session losing streak, the 30-share BSE Sensex rallied 503.27 points or 0.94 per cent to settle at 54,252.53. On similar lines, the broader NSE Nifty gained 144.35 points or 0.90 per cent to end at 16,170.15.

Sensex rallies 308 pts; Nifty hits fresh record at 15,436

Sensex rallies 308 pts; Nifty hits fresh record at 15,436

Rediff.com28 May 2021

Reliance Industries was the top gainer in the Sensex pack, soaring nearly 6 per cent, followed by M&M, HDFC twins, Kotak Bank, ITC and Bharti Airtel.

Sensex extends gains for 7th day; rallies 327 points

Sensex extends gains for 7th day; rallies 327 points

Rediff.com9 Oct 2020

ICICI Bank was the top gainer in the Sensex pack, rising around 3 per cent, followed by Axis Bank, HDFC twins, SBI, L&T, ONGC and Infosys. On the other hand, Sun Pharma, Asian Paints, Nestle India, UltraTech Cement and HUL declined. NSE Nifty rose by 79.60 points or 0.67 per cent to 11,914.20.

CDSCO panel recommends anti-Covid pill Molnupiravir for emergency use

CDSCO panel recommends anti-Covid pill Molnupiravir for emergency use

Rediff.com28 Dec 2021

The emergency use of the drug will be for adult COVID-19 patients with SpO2 93 percent and who have a high risk of progression of the disease including hospitalisation or death subject to certain conditions